Stifel Nicolaus restated their hold rating on shares of Imperva Inc (NYSE:IMPV) in a report released on Thursday morning. Stifel Nicolaus currently has a $47.00 target price on the software maker’s stock, down from their prior target price of $50.00.
IMPV has been the subject of several other reports. Piper Jaffray Companies reiterated a neutral rating and set a $58.00 price target on shares of Imperva in a report on Friday, October 13th. BidaskClub upgraded Imperva from a sell rating to a hold rating in a report on Tuesday, September 12th. KeyCorp reiterated a hold rating on shares of Imperva in a report on Tuesday, October 24th. Evercore ISI reiterated a buy rating and set a $56.00 price target on shares of Imperva in a report on Wednesday. Finally, William Blair lowered Imperva from an outperform rating to a market perform rating in a report on Tuesday, October 10th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has an average rating of Hold and a consensus target price of $52.38.
Shares of Imperva (NYSE IMPV) traded up $0.60 during midday trading on Thursday, reaching $41.20. The company’s stock had a trading volume of 222,500 shares, compared to its average volume of 448,881. Imperva has a 12-month low of $35.45 and a 12-month high of $52.40.
Imperva (NYSE:IMPV) last announced its quarterly earnings data on Wednesday, November 8th. The software maker reported $0.33 EPS for the quarter, topping the Zacks’ consensus estimate of $0.22 by $0.11. Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The firm had revenue of $83.89 million during the quarter, compared to analyst estimates of $83.79 million. During the same period last year, the company posted $0.08 EPS. The business’s quarterly revenue was up 22.6% compared to the same quarter last year.
COPYRIGHT VIOLATION NOTICE: This story was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright & trademark law. The original version of this story can be viewed at https://www.dispatchtribunal.com/2017/11/11/imperva-inc-impv-given-hold-rating-at-stifel-nicolaus.html.
In other news, Director Anthony J. Bettencourt sold 99,598 shares of the business’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the sale, the director now directly owns 99,598 shares in the company, valued at $4,341,476.82. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 2.20% of the company’s stock.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Van ECK Associates Corp increased its position in shares of Imperva by 0.8% during the second quarter. Van ECK Associates Corp now owns 8,346 shares of the software maker’s stock valued at $399,000 after purchasing an additional 64 shares during the period. Comerica Bank boosted its stake in Imperva by 0.8% in the 2nd quarter. Comerica Bank now owns 19,707 shares of the software maker’s stock valued at $978,000 after buying an additional 157 shares in the last quarter. Ameritas Investment Partners Inc. boosted its stake in Imperva by 18.7% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock valued at $141,000 after buying an additional 464 shares in the last quarter. Aperio Group LLC boosted its stake in Imperva by 8.1% in the 2nd quarter. Aperio Group LLC now owns 7,114 shares of the software maker’s stock valued at $340,000 after buying an additional 531 shares in the last quarter. Finally, Parametric Portfolio Associates LLC boosted its stake in Imperva by 5.3% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 11,614 shares of the software maker’s stock valued at $556,000 after buying an additional 581 shares in the last quarter. Institutional investors and hedge funds own 92.72% of the company’s stock.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.